New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
18:40 EDTNFLX, UCTT, RMBS, TGTX, JNJ, APA, CYS, CNI, HLX, CMG, SANM, TEPOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
News For NFLX;SANM;CMG;HLX;CNI;CYS;APA;JNJ;TGTX;RMBS;UCTT;TEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 24, 2014
12:29 EDTNFLX20th Century Fox signs TV deal with Canadian Shomi, The Hollywood Reporter says
Subscribe for More Information
12:14 EDTNFLXNetflix responds to Comcast's extortion claims, Variety reports
Subscribe for More Information
09:17 EDTNFLXComcast accuses TWC deal opponents of extortion, Re/code reports
Subscribe for More Information
07:51 EDTCMGChipotle Mexican Grill October volatility elevated
Subscribe for More Information
September 23, 2014
08:07 EDTJNJFDA Pediatric Advisory Committee to hold a meeting
Subscribe for More Information
07:34 EDTTGTXTG Therapeutics announces exercise of license option for TGR-1202
TG Therapeutics announced that it has exercised its option to license the global rights to TGR-1202, the company's novel, next generation PI3K-delta inhibitor from Rhizen Pharmaceuticals, S A. The company and Rhizen have to date been jointly developing TGR-1202 in a 50:50 joint venture. Given the successful development of TGR-1202, TG Therapeutics elected an early exercise of the company's license option. In exchange for the global license, Rhizen will receive a one-time, upfront cash payment of $4M and approximately 370,000 shares of TG Therapeutics' common stock. TG Therapeutics will receive exclusive worldwide rights, excluding India, for the development and commercialization of TGR-1202 for all indications. Rhizen will be eligible to receive regulatory filing, approval and sales based milestones in the aggregate of approximately $240M, and tiered royalties based on net sales.
06:48 EDTNFLXNetflix declines providing CRTC subscriber information, Globe and Mail says
Subscribe for More Information
05:54 EDTNFLXStocks with implied volatility movement; NFLX AMZN
Subscribe for More Information
05:49 EDTCMGStocks with implied volatility movement; HLF CMG
Subscribe for More Information
September 22, 2014
16:00 EDTNFLXOptions Update; September 22, 2014
iPath S&P 500 VIX Short-Term Futures up 91c to 28.14. Option volume leaders: AAPL TSLA NFLX C TWTR AMZN BP PBR CLF WLT according to Track Data.
07:50 EDTJNJDoctors continue to use morcellators despite FDA warning, J&J halt, WSJ says
Subscribe for More Information
07:25 EDTCNICitigroup to hold a conference
Industrials Conference to be held in Boston on September 22-24.
07:07 EDTJNJSynageva appoints Robert Bazemore as COO
Synageva announced the appointment of Robert Bazemore as Chief Operating Officer. Bazemore will oversee the planned global commercial launch of the company's lead program, sebelipase alfa for LAL Deficiency, and will have responsibility for the company's global commercial, market access and medical affairs operations. Bazemore last served at Johnson & Johnson (JNJ) in varoius roles including Vice President, Ethicon New Growth Platforms and President of Janssen Biotech, a part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
September 19, 2014
16:00 EDTNFLXOptions Update; September 19, 2014
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
05:18 EDTNFLXNetflix now available in France, Germany, four other European countries
Subscribe for More Information
September 18, 2014
16:00 EDTNFLXOptions Update; September 18, 2014
Subscribe for More Information
09:32 EDTNFLXNetflix domestic estimates raised at ITG Research
ITG raised Netflix's domestic estimates given an acceleration in August. The firm's data indicates a faster than expected improvement in ASP and improved churn trends. The analyst raised its Q3 domestic streaming revenue of $881.3M from $877.3M, above guidance of $877M and consensus of $876.3M.
07:22 EDTCNICanadian National fined for missing grain quota, Globe and Mail reports
The Canadian government is imposing its first monetary penalty under the recently passed Fair Rail for Grain Farmers Act, fining Canadian National Railway for failing to move its required minimum amount of grain each week, said The Globe and Mail, which noted that a CN spokesman said the company had not been informed by the government about the fine. Reference Link
06:00 EDTNFLXNetflix implied volatility of 26 at lower end of index mean range
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use